OriCiro Genomics: Shige Sasaki, Nasir Kato Bashiruddin

Tokyo-based Synthetic biology firm OriCiro Genomics has appointed Shigemasa (Shige) Sasaki as chief operating officer and chief business officer, and Nasir Kato Bashiruddin as chief technology officer.

Prior to joining OriCiro, Sasaki was president of the Japanese subsidiary of Unchained Labs, a US-based research tools company. Before that, he was Asia Pacific marketing director at GE Healthcare. He holds a BS in bioengineering from Fukui Prefectural University.

Bashiruddin used to be director of the platform innovation group at PeptiDream, a peptide drug discovery firm. He holds a PhD in chemistry from the University of Tokyo and a BS in biology from the University of Washington.